Effects of salazosulfapyridine and bucillamine on the active Arthus reaction and delayed-type hypersensitivity response.
スポンサーリンク
概要
- 論文の詳細を見る
Effects of salazosulfapyridine (SASP) and bucillamine (Bc), as disease-modifying antirheumatic drugs (DMARDs), on an active Arthus reaction and a delayed-type hypersensitivity (DTH) response were studied. SASP and Bc significantly suppressed the active Arthus reaction and DTH response. SASP and Bc also increased some cytokines in the DTH mice serum, such as interferon (IFN) -γ, interleukin (IL) -4, and IL-10.<BR>These results suggest that SASP and Bc activate all types of T cells, especially Th0 and Th2 involved in type IV (delayed-type) hypersensitivity, and also suppress type III hypersensitivity activated with immune complex.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発